These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 104869)

  • 1. Identification of metabolites of valproic acid in serum of humans, dog, rat, and mouse.
    Jakobs C; Löscher W
    Epilepsia; 1978 Dec; 19(6):591-602. PubMed ID: 104869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of metabolites of valproic acid in plasma of epileptic patients.
    Löscher W
    Epilepsia; 1981 Apr; 22(2):169-78. PubMed ID: 6781893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
    Rettenmeier AW; Gordon WP; Prickett KS; Levy RH; Baillie TA
    Drug Metab Dispos; 1986; 14(4):454-64. PubMed ID: 2873993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
    Löscher W; Nau H
    J Pharmacol Exp Ther; 1983 Sep; 226(3):845-54. PubMed ID: 6411902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
    Tang W; Abbott FS
    Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative ion chemical ionization gas chromatography/mass spectrometry of valproic acid metabolites.
    Kassahun K; Burton R; Abbott FS
    Biomed Environ Mass Spectrom; 1989 Oct; 18(10):918-26. PubMed ID: 2508808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of valproic acid in patients using negative-ion chemical ionization gas chromatography-mass spectrometry.
    Kassahun K; Farrell K; Zheng JJ; Abbott F
    J Chromatogr; 1990 May; 527(2):327-41. PubMed ID: 2117614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of thiol-conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry.
    Tang W; Abbott FS
    J Mass Spectrom; 1996 Aug; 31(8):926-36. PubMed ID: 8799319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate metabolites in high-dose valproate plus phenytoin therapy.
    Sugimoto T; Muro H; Woo M; Nishida N; Murakami K
    Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of valproic acid and its metabolites using gas chromatography with mass-selective detection: application to serum and urine samples from sheep.
    Yu D; Gordon JD; Zheng J; Panesar SK; Riggs KW; Rurak DW; Abbott FS
    J Chromatogr B Biomed Appl; 1995 Apr; 666(2):269-81. PubMed ID: 7633603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary metabolites of valproic acid in epileptic patients.
    Katayama H; Watanabe M; Yoshitomi H; Yoshida H; Kimoto H; Kamiya A; Hayashi T; Akimura T
    Biol Pharm Bull; 1998 Mar; 21(3):304-7. PubMed ID: 9556166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation and washout kinetics of valproic acid and its active metabolites.
    Pollack GM; McHugh WB; Gengo FM; Ermer JC; Shen DD
    J Clin Pharmacol; 1986; 26(8):668-76. PubMed ID: 3098806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
    Kondo T; Otani K; Hirano T; Kaneko S; Fukushima Y
    Br J Clin Pharmacol; 1990 Jan; 29(1):116-9. PubMed ID: 2105099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
    Rettenmeier AW; Prickett KS; Gordon WP; Bjorge SM; Chang SL; Levy RH; Baillie TA
    Drug Metab Dispos; 1985; 13(1):81-96. PubMed ID: 2858383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy.
    Löscher W; Nau H; Siemes H
    Epilepsia; 1988; 29(3):311-6. PubMed ID: 3131137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiotopic differentiation during the biotransformation of valproic acid to the hepatotoxic olefin 2-n-propyl-4-pentenoic acid.
    Porubek DJ; Barnes H; Meier GP; Theodore LJ; Baillie TA
    Chem Res Toxicol; 1989; 2(1):35-40. PubMed ID: 2519229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of valproic acid and its metabolites during continued treatment in dogs.
    Löscher W
    J Vet Pharmacol Ther; 1981 Jun; 4(2):111-9. PubMed ID: 6818360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolic fate of valproic acid in the rat using stable isotope techniques.
    Rettenmeier AW; Gordon WP; Barnes H; Baillie TA
    Xenobiotica; 1987 Oct; 17(10):1147-57. PubMed ID: 3122428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K; Farrell K; Abbott F
    Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.